Latest Competition News

Flagship Investments reported a challenging half-year with a 9.8% portfolio decline and a comprehensive loss of $6.4 million, yet maintained its commitment to dividends with a 5.1 cent fully franked interim payout.

Apiam Animal Health’s acquisition scheme by Adamantem Capital has been legally approved, leading to the suspension of its shares on the ASX. Key dates for dividend payments and scheme implementation are now set.

Brisbane Broncos Limited projects a significant profit increase for 2025, driven by premiership wins in both their NRL and NRLW teams and boosted commercial revenues.

Bridge SaaS Limited has issued a correction to its Appendix 4C quarterly cash flow report, clarifying previously omitted financing facilities without affecting its cash position or operating results.

Murray Cod Australia announces the departure of CEO Ross Anderson, with interim leadership stepping in as the company searches for a new chief executive.

FirstWave has unveiled a strategic shift towards AI-powered compliance management, backed by strong user growth for its Open-AudIT platform and significant cost savings from restructuring.

Acusensus Limited has settled its patent litigation with Redflex Traffic Systems, issuing over six million shares and paying US$6 million in cash to resolve the dispute. The agreement clears the way for Acusensus to continue its road safety technology operations unimpeded.

Native Mineral Resources’ board members have converted $1.62 million in options into 63 million new shares, reinforcing their commitment to the company’s growth strategy and key projects in northern Queensland.

REA Group Ltd reported a solid 5% revenue increase for H1 FY26, driven by strong buyer demand and strategic AI integration, alongside announcing a $200 million on-market share buy-back.

Immutep Limited has reached the halfway mark in enrolling patients for its global Phase III TACTI-004 trial, testing a novel immunotherapy combo in first-line non-small cell lung cancer. The trial remains on track for key milestones this year, signaling steady progress in a critical oncology space.

Rio Tinto has officially ended merger discussions with Glencore, citing an inability to reach a deal that benefits shareholders. The decision underscores Rio Tinto’s disciplined approach to long-term value creation.

European Lithium has sold 2.5 million shares in Critical Metals Corp for around A$45 million, strengthening its cash position while maintaining a significant strategic stake.